Viewing Study NCT05212532


Ignite Creation Date: 2025-12-24 @ 9:45 PM
Ignite Modification Date: 2025-12-29 @ 4:53 PM
Study NCT ID: NCT05212532
Status: UNKNOWN
Last Update Posted: 2022-01-28
First Post: 2021-08-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Proof-of-Concept Study Evaluating EOM613 in COVID-19 Infected Patients With Severe Symptoms
Sponsor: EOM Pharmaceuticals
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-08-09
Start Date Type: ACTUAL
Primary Completion Date: 2022-02-28
Primary Completion Date Type: ESTIMATED
Completion Date: 2022-03-30
Completion Date Type: ESTIMATED
First Submit Date: 2021-08-25
First Submit QC Date: None
Study First Post Date: 2022-01-28
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-01-27
Last Update Post Date: 2022-01-28
Last Update Post Date Type: ACTUAL